CDK16_HUMAN - dbPTM
CDK16_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDK16_HUMAN
UniProt AC Q00536
Protein Name Cyclin-dependent kinase 16
Gene Name CDK16
Organism Homo sapiens (Human).
Sequence Length 496
Subcellular Localization Cytoplasm. Cytoplasmic vesicle, secretory vesicle. Cell membrane
Peripheral membrane protein
Cytoplasmic side. Cell junction, synapse, synaptosome. Colocalizes with insulin in pancreas islets. Recruited to the cell membrane by CCNY.
Protein Description Protein kinase that plays a role in vesicle-mediated transport processes and exocytosis. Regulates GH1 release by brain neurons. Phosphorylates NSF, and thereby regulates NSF oligomerization. Required for normal spermatogenesis. Regulates neuron differentiation and dendrite development (By similarity). Plays a role in the regulation of insulin secretion in response to changes in blood glucose levels. Can phosphorylate CCNY at 'Ser-336' (in vitro)..
Protein Sequence MDRMKKIKRQLSMTLRGGRGIDKTNGAPEQIGLDESGGGGGSDPGEAPTRAAPGELRSARGPLSSAPEIVHEDLKMGSDGESDQASATSSDEVQSPVRVRMRNHPPRKISTEDINKRLSLPADIRLPEGYLEKLTLNSPIFDKPLSRRLRRVSLSEIGFGKLETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSSSMPDSGRPAFRVVDTEF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
12PhosphorylationKKIKRQLSMTLRGGR
HHHHHHHHCHHCCCC
11.0330266825
14PhosphorylationIKRQLSMTLRGGRGI
HHHHHHCHHCCCCCC
15.2130266825
19MethylationSMTLRGGRGIDKTNG
HCHHCCCCCCCCCCC
41.54-
24PhosphorylationGGRGIDKTNGAPEQI
CCCCCCCCCCCCCCC
34.8330624053
30 (in isoform 2)Phosphorylation-33.71-
30PhosphorylationKTNGAPEQIGLDESG
CCCCCCCCCCCCCCC
33.71-
36PhosphorylationEQIGLDESGGGGGSD
CCCCCCCCCCCCCCC
42.2625159151
42PhosphorylationESGGGGGSDPGEAPT
CCCCCCCCCCCCCCC
43.8625159151
58PhosphorylationAAPGELRSARGPLSS
CCCCCHHHCCCCCCC
34.6419369195
64PhosphorylationRSARGPLSSAPEIVH
HHCCCCCCCCCCHHC
27.8230266825
65PhosphorylationSARGPLSSAPEIVHE
HCCCCCCCCCCHHCC
56.3730266825
78PhosphorylationHEDLKMGSDGESDQA
CCHHCCCCCCCCCCC
38.6622167270
82PhosphorylationKMGSDGESDQASATS
CCCCCCCCCCCCCCC
40.3222167270
86PhosphorylationDGESDQASATSSDEV
CCCCCCCCCCCCCCC
26.8422167270
88PhosphorylationESDQASATSSDEVQS
CCCCCCCCCCCCCCC
26.6922167270
89PhosphorylationSDQASATSSDEVQSP
CCCCCCCCCCCCCCC
35.1922167270
90PhosphorylationDQASATSSDEVQSPV
CCCCCCCCCCCCCCC
33.1722167270
95PhosphorylationTSSDEVQSPVRVRMR
CCCCCCCCCCCHHCC
30.4529255136
108AcetylationMRNHPPRKISTEDIN
CCCCCCCCCCHHHHH
46.9419828321
110PhosphorylationNHPPRKISTEDINKR
CCCCCCCCHHHHHHH
28.8727273156
111PhosphorylationHPPRKISTEDINKRL
CCCCCCCHHHHHHHH
40.9423401153
116UbiquitinationISTEDINKRLSLPAD
CCHHHHHHHHCCCCC
55.86-
116PhosphorylationISTEDINKRLSLPAD
CCHHHHHHHHCCCCC
55.8627251275
116AcetylationISTEDINKRLSLPAD
CCHHHHHHHHCCCCC
55.8619828331
119PhosphorylationEDINKRLSLPADIRL
HHHHHHHCCCCCCCC
36.0229255136
130PhosphorylationDIRLPEGYLEKLTLN
CCCCCCCHHHHHCCC
15.2728152594
133UbiquitinationLPEGYLEKLTLNSPI
CCCCHHHHHCCCCCC
44.1521890473
135PhosphorylationEGYLEKLTLNSPIFD
CCHHHHHCCCCCCCC
34.6530266825
138PhosphorylationLEKLTLNSPIFDKPL
HHHHCCCCCCCCCCH
23.6122322096
139PhosphorylationEKLTLNSPIFDKPLS
HHHCCCCCCCCCCHH
30.1427251275
143UbiquitinationLNSPIFDKPLSRRLR
CCCCCCCCCHHHHHH
36.7921890473
146PhosphorylationPIFDKPLSRRLRRVS
CCCCCCHHHHHHHCC
24.7130266825
152PhosphorylationLSRRLRRVSLSEIGF
HHHHHHHCCHHHHCC
5.6627251275
153PhosphorylationSRRLRRVSLSEIGFG
HHHHHHCCHHHHCCC
25.1129255136
155PhosphorylationRLRRVSLSEIGFGKL
HHHHCCHHHHCCCCH
21.4729255136
164PhosphorylationIGFGKLETYIKLDKL
HCCCCHHEEEEEEEC
40.7724719451
167UbiquitinationGKLETYIKLDKLGEG
CCHHEEEEEEECCCC
39.9721890473
169PhosphorylationLETYIKLDKLGEGTY
HHEEEEEEECCCCEE
38.8524719451
175PhosphorylationLDKLGEGTYATVYKG
EEECCCCEEEEEECC
12.9929255136
176PhosphorylationDKLGEGTYATVYKGK
EECCCCEEEEEECCC
15.9027273156
178PhosphorylationLGEGTYATVYKGKSK
CCCCEEEEEECCCCC
17.6029255136
180PhosphorylationEGTYATVYKGKSKLT
CCEEEEEECCCCCCC
15.0729255136
183AcetylationYATVYKGKSKLTDNL
EEEEECCCCCCCCCE
40.0225953088
184PhosphorylationATVYKGKSKLTDNLV
EEEECCCCCCCCCEE
41.3824719451
185PhosphorylationTVYKGKSKLTDNLVA
EEECCCCCCCCCEEE
59.9127251275
185AcetylationTVYKGKSKLTDNLVA
EEECCCCCCCCCEEE
59.9125953088
193PhosphorylationLTDNLVALKEIRLEH
CCCCEEEEEHHHCCC
3.8924719451
194UbiquitinationTDNLVALKEIRLEHE
CCCEEEEEHHHCCCC
41.1621890473
207UbiquitinationHEEGAPCTAIREVSL
CCCCCCCCHHHHHHH
24.8621890473
207PhosphorylationHEEGAPCTAIREVSL
CCCCCCCCHHHHHHH
24.8628857561
212PhosphorylationPCTAIREVSLLKDLK
CCCHHHHHHHHHHHH
3.3424719451
213PhosphorylationCTAIREVSLLKDLKH
CCHHHHHHHHHHHHC
24.1924719451
216UbiquitinationIREVSLLKDLKHANI
HHHHHHHHHHHCCCE
67.33-
217UbiquitinationREVSLLKDLKHANIV
HHHHHHHHHHCCCEE
62.0021890473
227PhosphorylationHANIVTLHDIIHTEK
CCCEEEHHHHHHCCC
18.1724719451
229PhosphorylationNIVTLHDIIHTEKSL
CEEEHHHHHHCCCHH
1.4124719451
238PhosphorylationHTEKSLTLVFEYLDK
HCCCHHHHHHHHHCH
5.1524719451
241UbiquitinationKSLTLVFEYLDKDLK
CHHHHHHHHHCHHHH
37.3921890473
250PhosphorylationLDKDLKQYLDDCGNI
HCHHHHHHHHHHCCC
15.5424719451
268UbiquitinationHNVKLFLFQLLRGLA
HHHHHHHHHHHHHHH
3.6421890473
288UbiquitinationKVLHRDLKPQNLLIN
CHHCCCCCHHCEEEC
49.17-
301UbiquitinationINERGELKLADFGLA
ECCCCCEEEHHHHCC
37.0121890473
319PhosphorylationSIPTKTYSNEVVTLW
CCCCCCCCCCEEEEE
31.5712154078
380PhosphorylationFIFRILGTPTEETWP
HHHHHHCCCCCCCCC
24.48-
391PhosphorylationETWPGILSNEEFKTY
CCCCCCCCCHHHHHC
40.03-
425UbiquitinationDGADLLTKLLQFEGR
CHHHHHHHHHHHCCC
47.36-
455UbiquitinationSLGERIHKLPDTTSI
HHHHHHHHCCCCCEE
60.3821890473
466UbiquitinationTTSIFALKEIQLQKE
CCEEEEEEEHHHHHH
49.7121890473
472UbiquitinationLKEIQLQKEASLRSS
EEEHHHHHHHHHHCC
64.93-
478PhosphorylationQKEASLRSSSMPDSG
HHHHHHHCCCCCCCC
31.8723186163
479PhosphorylationKEASLRSSSMPDSGR
HHHHHHCCCCCCCCC
24.9923186163
480PhosphorylationEASLRSSSMPDSGRP
HHHHHCCCCCCCCCC
35.2625159151
529Ubiquitination----------------------------------------
----------------------------------------
21890473
540Ubiquitination---------------------------------------------------
---------------------------------------------------
21890473
553Phosphorylation----------------------------------------------------------------
----------------------------------------------------------------
27251275
554Phosphorylation-----------------------------------------------------------------
-----------------------------------------------------------------
24719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
12SPhosphorylationKinasePRKACAP17612
GPS
12SPhosphorylationKinasePKA_GROUP-PhosphoELM
12SPhosphorylationKinasePKA-FAMILY-GPS
12SPhosphorylationKinaseBRSK2Q8IWQ3
Uniprot
95SPhosphorylationKinaseCDK_GROUP-PhosphoELM
95SPhosphorylationKinaseCDK5Q00535
Uniprot
95SPhosphorylationKinaseCDK-FAMILY-GPS
110SPhosphorylationKinasePKA-FAMILY-GPS
110SPhosphorylationKinasePKA_GROUP-PhosphoELM
110SPhosphorylationKinasePRKACAP17612
GPS
119SPhosphorylationKinasePKA-FAMILY-GPS
119SPhosphorylationKinasePRKACAP17612
GPS
119SPhosphorylationKinasePKA_GROUP-PhosphoELM
138SPhosphorylationKinaseCDK2P24941
PSP
153SPhosphorylationKinasePKA-FAMILY-GPS
153SPhosphorylationKinasePRKACAP17612
GPS
153SPhosphorylationKinasePKA_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
153SPhosphorylation

18669648

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDK16_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CD5R1_HUMANCDK5R1physical
12084709
S10AA_HUMANS100A10physical
9197417
1433Z_HUMANYWHAZphysical
9197417
1433F_HUMANYWHAHphysical
9197417
1433T_HUMANYWHAQphysical
9197417
A4_HUMANAPPphysical
21832049
CSK22_HUMANCSNK2A2physical
23602568
PP2AB_HUMANPPP2CBphysical
23602568
2ABA_HUMANPPP2R2Aphysical
23602568
CSK2B_HUMANCSNK2Bphysical
23602568
ZBT14_HUMANZBTB14physical
25416956
APBP2_HUMANAPPBP2physical
25416956
ATRIP_HUMANATRIPphysical
25416956
BRCA1_HUMANBRCA1physical
25184681
CCYL1_HUMANCCNYL1physical
25852190
KPYM_HUMANPKMphysical
25852190
1433E_HUMANYWHAEphysical
25852190
1433Z_HUMANYWHAZphysical
25852190
CCYL1_HUMANCCNYL1physical
26186194
CDK17_HUMANCDK17physical
26186194
CDK18_HUMANCDK18physical
26186194
2ABD_HUMANPPP2R2Dphysical
26186194
ICK_HUMANICKphysical
26186194
BRCA1_HUMANBRCA1physical
26186194
SNX27_HUMANSNX27physical
26186194
I20L2_HUMANISG20L2physical
26496610
CCYL1_HUMANCCNYL1physical
26496610
CDK17_HUMANCDK17physical
28514442
CDK18_HUMANCDK18physical
28514442
CCYL1_HUMANCCNYL1physical
28514442
ICK_HUMANICKphysical
28514442
CCNY_HUMANCCNYphysical
28514442
CSK22_HUMANCSNK2A2physical
28514442
CSK21_HUMANCSNK2A1physical
28514442
T2FA_HUMANGTF2F1physical
28514442
MCMBP_HUMANMCMBPphysical
28514442
KCTD3_HUMANKCTD3physical
27173435
KI13B_HUMANKIF13Bphysical
27173435
ZBT21_HUMANZBTB21physical
27173435
GGYF1_HUMANGIGYF1physical
27173435
LRFN1_HUMANLRFN1physical
27173435
SRGP2_HUMANSRGAP2physical
27173435
SI1L1_HUMANSIPA1L1physical
27173435
LIMA1_HUMANLIMA1physical
27173435
MAGI1_HUMANMAGI1physical
27173435
TESK2_HUMANTESK2physical
27173435
DCLK1_HUMANDCLK1physical
27173435
SRS12_HUMANSRSF12physical
27173435
SYDE1_HUMANSYDE1physical
27173435
AGAP1_HUMANAGAP1physical
27173435
F110B_HUMANFAM110Bphysical
27173435
UBP21_HUMANUSP21physical
27173435
AN34A_HUMANANKRD34Aphysical
27173435
FA53C_HUMANFAM53Cphysical
27173435
F110A_HUMANFAM110Aphysical
27173435
TBC25_HUMANTBC1D25physical
27173435
MAST3_HUMANMAST3physical
27173435
HDAC4_HUMANHDAC4physical
27173435
RAB3I_HUMANRAB3IPphysical
27173435
TIAM1_HUMANTIAM1physical
27173435
NADK_HUMANNADKphysical
27173435
M3K21_HUMANKIAA1804physical
27173435
NF1_HUMANNF1physical
27173435
CBY1_HUMANCBY1physical
27173435
NGAP_HUMANRASAL2physical
27173435
MELK_HUMANMELKphysical
27173435
CING_HUMANCGNphysical
27173435
PKHA7_HUMANPLEKHA7physical
27173435
AFAD_HUMANMLLT4physical
27173435
DEP1B_HUMANDEPDC1Bphysical
27173435
SH3B4_HUMANSH3BP4physical
27173435
KIF1C_HUMANKIF1Cphysical
27173435
PKHA5_HUMANPLEKHA5physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDK16_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-14; SER-36;SER-42; SER-65; SER-78; SER-82; SER-86; THR-88; SER-89; SER-90;SER-95; SER-110; SER-119; THR-135; SER-138; SER-153; SER-155; SER-478AND SER-480, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138; SER-153 ANDSER-155, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-36; SER-42;SER-65; SER-78; SER-82; SER-95; SER-110; SER-119; SER-138; SER-153 ANDSER-480, AND MASS SPECTROMETRY.
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry.";
Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.;
Mol. Cell. Proteomics 6:537-547(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119; SER-138 ANDSER-153, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119 AND SER-153, ANDMASS SPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-175, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-176, AND MASSSPECTROMETRY.

TOP